These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 35567658

  • 1. Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?
    Yurista SR, Chen S, Welsh A, Tang WHW, Nguyen CT.
    Curr Heart Fail Rep; 2022 Aug; 19(4):180-190. PubMed ID: 35567658
    [Abstract] [Full Text] [Related]

  • 2. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED.
    Circ Res; 2021 May 14; 128(10):1487-1513. PubMed ID: 33983836
    [Abstract] [Full Text] [Related]

  • 3. Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction.
    Sun Q, Güven B, Wagg CS, Almeida de Oliveira A, Silver H, Zhang L, Chen B, Wei K, Ketema EB, Karwi QG, Persad KL, Vu J, Wang F, Dyck JRB, Oudit GY, Lopaschuk GD.
    Cardiovasc Res; 2024 Mar 30; 120(4):360-371. PubMed ID: 38193548
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of Metabolic Flexibility in the Failing Heart.
    Karwi QG, Uddin GM, Ho KL, Lopaschuk GD.
    Front Cardiovasc Med; 2018 Mar 30; 5():68. PubMed ID: 29928647
    [Abstract] [Full Text] [Related]

  • 6. Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
    Selvaraj S, Kelly DP, Margulies KB.
    Circulation; 2020 Jun 02; 141(22):1800-1812. PubMed ID: 32479196
    [Abstract] [Full Text] [Related]

  • 7. Retained Metabolic Flexibility of the Failing Human Heart.
    Watson WD, Green PG, Lewis AJM, Arvidsson P, De Maria GL, Arheden H, Heiberg E, Clarke WT, Rodgers CT, Valkovič L, Neubauer S, Herring N, Rider OJ.
    Circulation; 2023 Jul 11; 148(2):109-123. PubMed ID: 37199155
    [Abstract] [Full Text] [Related]

  • 8. Cardiac ketone body metabolism.
    Abdul Kadir A, Clarke K, Evans RD.
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun 01; 1866(6):165739. PubMed ID: 32084511
    [Abstract] [Full Text] [Related]

  • 9. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A, Milner K, Gupta A, Lopaschuk GD.
    Curr Pharm Des; 2015 Jun 01; 21(25):3654-64. PubMed ID: 26166604
    [Abstract] [Full Text] [Related]

  • 10. Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue.
    Manolis AS, Manolis TA, Manolis AA.
    Int J Mol Sci; 2023 Feb 10; 24(4):. PubMed ID: 36834946
    [Abstract] [Full Text] [Related]

  • 11. Ketone therapy for heart failure: current evidence for clinical use.
    Takahara S, Soni S, Maayah ZH, Ferdaoussi M, Dyck JRB.
    Cardiovasc Res; 2022 Mar 16; 118(4):977-987. PubMed ID: 33705533
    [Abstract] [Full Text] [Related]

  • 12. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.
    Ho KL, Zhang L, Wagg C, Al Batran R, Gopal K, Levasseur J, Leone T, Dyck JRB, Ussher JR, Muoio DM, Kelly DP, Lopaschuk GD.
    Cardiovasc Res; 2019 Sep 01; 115(11):1606-1616. PubMed ID: 30778524
    [Abstract] [Full Text] [Related]

  • 13. Ketones can become the major fuel source for the heart but do not increase cardiac efficiency.
    Ho KL, Karwi QG, Wagg C, Zhang L, Vo K, Altamimi T, Uddin GM, Ussher JR, Lopaschuk GD.
    Cardiovasc Res; 2021 Mar 21; 117(4):1178-1187. PubMed ID: 32402081
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Failing Heart Relies on Ketone Bodies as a Fuel.
    Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, Koves T, Gardell SJ, Krüger M, Hoppel CL, Lewandowski ED, Crawford PA, Muoio DM, Kelly DP.
    Circulation; 2016 Feb 23; 133(8):698-705. PubMed ID: 26819376
    [Abstract] [Full Text] [Related]

  • 16. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ.
    Cardiovasc Res; 2009 Feb 15; 81(3):420-8. PubMed ID: 18854380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PGRMC1 Ablation Protects from Energy-Starved Heart Failure by Promoting Fatty Acid/Pyruvate Oxidation.
    Lee SR, Mukae M, Jeong KJ, Park SH, Shin HJ, Kim SW, Won YS, Kwun HJ, Baek IJ, Hong EJ.
    Cells; 2023 Feb 27; 12(5):. PubMed ID: 36899888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.